-
AstraZeneca COVID-19 Vaccine Authorized for Emergency Use by WHO
americanpharmaceuticalreview
February 19, 2021
AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunization to prevent COVID-19 in individuals 18 years of age and older, including those over 65.
-
Oxford University launches Covid-19 vaccine study in children
pharmaceutical-technology
February 18, 2021
The University of Oxford has launched the first study of ChAdOx1 nCoV-19 Covid-19 vaccine in children and young adults.
-
Pfizer-BioNTech’s Covid-19 vaccine-immunised sera neutralises SA variant
pharmaceutical-technology
February 18, 2021
Pfizer and BioNTech have reported results from an in vitro study, which showed the capability of sera from individuals immunised with their Covid-19 vaccine (BNT162b2) in neutralising SARS-CoV-2 with the South African variant spike protein.
-
FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site
contractpharma
February 18, 2021
Billingham site to support the manufacture of up to 180 million doses Novavax’ NVX-CoV2373 COVID-19 vaccine candidate.
-
EC buys additional 150 mn doses of Moderna’s COVID-19 vaccine
expresspharma
February 18, 2021
Moderna announced that the European Commission purchased an additional 150 million doses of the COVID-19 Vaccine Moderna, which are scheduled to be delivered in the third and fourth quarter of 2021.
-
Research reveals Pfizer-BioNTech COVID-19 vaccine elicits strong immune response with single dose
expresspharma
February 18, 2021
The response among those previously infected was so effective that it opens the debate as to whether one dose of the vaccine may suffice, the researchers said.
-
South Africa asks SII to take back one million doses of COVID-19 vaccine: Reports
expresspharma
February 18, 2021
South Africa’s health minister had informed last week that the government could sell AstraZeneca’s vaccine.
-
18-19 COVID-19 vaccine candidates in pipeline: Union Health Minister
expresspharma
February 18, 2021
About 18-19 vaccine candidates against COVID-19 are in the pipeline and in different clinical trial stages, said Health Minister Harsh Vardhan.
-
Mexico gets AstraZeneca doses from India
expresspharma
February 18, 2021
The shipment amounts to about 42 per cent of the two million doses of the AstraZeneca and Oxford University vaccine the country plans to import from India.
-
mRNA COVID-19 vaccine from Sanofi will not ready this year: CEO
expresspharma
February 18, 2021
A COVID-19 vaccine candidate developed by Sanofi and US group Translate Bio “will not be ready this year,” said the company’s CEO to Le Journal du Dimanche newspaper.